Source:http://linkedlifedata.com/resource/pubmed/id/20550781
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2010-6-16
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1815-7920
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
927; author reply 928
|
pubmed:meshHeading |
pubmed-meshheading:20550781-Antitubercular Agents,
pubmed-meshheading:20550781-Clinical Trials as Topic,
pubmed-meshheading:20550781-Follow-Up Studies,
pubmed-meshheading:20550781-Humans,
pubmed-meshheading:20550781-Molecular Epidemiology,
pubmed-meshheading:20550781-Recurrence,
pubmed-meshheading:20550781-Time Factors,
pubmed-meshheading:20550781-Tuberculosis
|
pubmed:year |
2010
|
pubmed:articleTitle |
Adequacy of 6-month follow-up in chemotherapy trials.
|
pubmed:publicationType |
Letter,
Comment
|